Using our large scale polymerase chain reaction (PCR) based manufacturing platform, we manufacture large quantities of linear DNA for various markets. Whether for supply chain security, brand protection, law enforcement or drug candidate or biologic applications, it is our goal to help establish secure flourishing environments that foster quality, integrity and success.
With secure taggants, high-resolution DNA authentication, and comprehensive reporting, our SigNature® molecular tag technologies are designed to deliver what we believe to be the greatest levels of security, deterrence and legal recourse strength. Under our wholly owned subsidiary, LineaRx, Inc. (LRx), we supply DNA for use in the in vitro medical diagnostics, preclinical biotechnology and preclinical drug and biologic development and manufacturing markets. We are also engaged in preclinical and animal drug candidate development directly and with collaborators focusing on therapeutically relevant DNA constructs manufactured via our PCR-based DNA production platform.
Management Team
Stock Information
Shareholder Info – Investor Relations
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, NY 11790
investor@adnas.com | 631.240.8800
Sanjay M. Hurry
Executive Director, Investor Relations and Corporate Communications
sanjay.hurry@adnas.com | M: 917-733-5573
Transfer Agent
American Stock Transfer and Trust Company
6201 15th Ave.
Brooklyn, New York 11219
Tel: 718.921.8210
Fax: 718.921.8355
http://www.amstock.com/main/
For additional information, please click here.
SEC Counsel
.
Applied DNA Sciences is not able to purchase shares on your behalf, and it is not possible for you to purchase shares directly from us. Please contact a stockbroker, bank, or independent financial advisor, who should be able to act on your behalf.
Auditor
Marcum LLP
10 Melville Park Road
Melville, NY 11790
tel: 631 414 4000
fax: 631 414 4001
http://www.marcumllp.com
Board of Directors
Applied DNA’s Board of Directors consists of individuals with proven leadership skills, broad management experience
in
established companies, and their reputation as independent thinkers.
With experience in fields ranging from Bioagriculture to Zoology, the company will continue to benefit from the
Board’s diversity of experience and opinions.
